These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 6803905)
1. Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations. Demacker PN; Schade RW; Stalenhoef AF; Stuyt PM; van't Laar A Br Med J (Clin Res Ed); 1982 Apr; 284(6324):1213-5. PubMed ID: 6803905 [TBL] [Abstract][Full Text] [Related]
2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
4. Results of a study to determine the effects of three oral contraceptives on serum lipoprotein levels. Pasquale SA; Murphy RJ; Norwood PK; McBride LC Fertil Steril; 1982 Nov; 38(5):559-63. PubMed ID: 7128841 [TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
6. Effects of oral contraceptives on serum lipid profiles of women runners. Gray DP; Harding E; Dale E Fertil Steril; 1983 Apr; 39(4):510-4. PubMed ID: 6832406 [TBL] [Abstract][Full Text] [Related]
7. Serum lipids and proteins during treatment with a new oral contraceptive combination containing desogestrel. Penttilä IM; Bergink EW; Holma P; Hulkko S; Makkonen M; Pyörälä T; Castrén O Eur J Obstet Gynecol Reprod Biol; 1983 Dec; 16(4):275-81. PubMed ID: 6232161 [TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen. Nash AL; Cornish EJ; Hain R Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411 [TBL] [Abstract][Full Text] [Related]
9. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases. Cai HJ; Li ZX; Yang SM Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460 [TBL] [Abstract][Full Text] [Related]
10. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study. Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913 [TBL] [Abstract][Full Text] [Related]
11. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Larsson-Cohn U; Wallentin L; Zador G Horm Metab Res; 1979 Jul; 11(7):437-40. PubMed ID: 225252 [TBL] [Abstract][Full Text] [Related]
12. Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations. Percival-Smith RK; Frohlich J; Jones WN; Abercrombie BA Contraception; 1988 Jul; 38(1):19-26. PubMed ID: 3168443 [TBL] [Abstract][Full Text] [Related]
13. Effect of a controlled exercise program on serum lipoprotein levels in women on oral contraceptives. Wynne TP; Frey MA; Laubach LL; Glueck CJ Metabolism; 1980 Dec; 29(12):1267-71. PubMed ID: 7453571 [TBL] [Abstract][Full Text] [Related]
14. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
15. Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls. de Graaf J; Swinkels DW; Demacker PN; de Haan AF; Stalenhoef AF J Clin Endocrinol Metab; 1993 Jan; 76(1):197-202. PubMed ID: 8421088 [TBL] [Abstract][Full Text] [Related]
16. Effects of oral contraceptives on lipoprotein triglyceride and cholesterol: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):725-31. PubMed ID: 7065054 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a combined oral contraceptive pill in black Zimbabwean women. Kasule J; Mbizvo M; Makuyana D; Masona D Cent Afr J Med; 1991 Dec; 37(12):403-9. PubMed ID: 1806254 [TBL] [Abstract][Full Text] [Related]
18. Effects of pregnancy, postpartum lactation, and oral contraceptive use on the lipoprotein cholesterol/triglyceride ratio. Knopp RH; Bergelin RO; Wahl PW; Walden CE Metabolism; 1985 Oct; 34(10):893-9. PubMed ID: 4046832 [TBL] [Abstract][Full Text] [Related]
19. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related]
20. Relationship of exercise, oral contraceptive use, and body fat to concentrations of plasma lipids and lipoprotein cholesterol in young women. Merians DR; Haskell WL; Vranizan KM; Phelps J; Woods PD; Superko R Am J Med; 1985 Jun; 78(6 Pt 1):913-9. PubMed ID: 3874544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]